CytoDyn Inc. logo

CytoDyn Inc.

OTC:CYDY

Overview | Financials
Company Name CytoDyn Inc.
Symbol CYDY
Currency USD
Price 0.18
Market Cap 167,607,360
Dividend Yield 0%
52-week-range 0.15 - 0.48
Industry Biotechnology
Sector Healthcare
CEO Mr. Antonio Migliarese CPA
Website https://www.cytodyn.com

An error occurred while fetching data.

About CytoDyn Inc.

CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (“COVID-19”). It is

Related Stocks

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPHRY

0.917 USD

MariMed Inc. logo

MariMed Inc.

MRMD

0.31 USD

Goodness Growth Holdings, Inc. logo

Goodness Growth Holdings, Inc.

GDNSF

0.2 USD

Panamera Holdings Corporation logo

Panamera Holdings Corporation

PHCI

1.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD